-
-
-
-
-
-
-
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors
-
-
-
-
-
-
-
Defence Therapeutics Announces Warrant Terms Amendment
-
-
-
-
-
-
-
Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
-
-
-
-
-
-
-
Defence Therapeutics Announces Convertible Debenture Conversion
-
-
-
-
-
-
-
Defence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin
-
-
-
-
-
-
-
Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology
-
-
-
-
-
-
-
Defence Fortifies Patent Portfolio
-
443,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

